Fluid Resuscitation: State of the Science for Treating Combat Casualties and Civilian Injuries (1999)
Chapter: C: Conference Agenda
C Conference Agenda
Conference on Resuscitation Fluid Design and Resuscitation Protocols for Combat Casualties
National Academy of Sciences Auditorium
2101 Constitution Avenue, N.W.
Washington, D.C.
|
Thursday, September 17, 1998 |
|
|
8:30 a.m. |
WELCOMING REMARKS AND OVERVIEW OF THE CONFERENCE |
|
|
Clyde J. Behney Deputy Executive Officer Institute of Medicine |
|
|
Anna Johnson-Winegar, Ph.D. Head, Human Systems Department Office of Naval Research |
|
|
David E. Longnecker, M.D. Robert D. Dripps Professor and Chair Department of Anesthesia University of Pennsylvania Health System Committee Chair |
|
9:00 |
PANEL 1: OVERVIEW OF FLUID RESUSCITATION (15-minute presentations, each followed by 5 minutes of discussion) |
|
|
Ronald F. Bellamy, M.D., Colonel, USA, Retired Borden Institute, Walter Reed Army Institute of Research Trauma Epidemiology of Combat Casualties |
|
|
Howard Champion, M.D. University of Maryland, Baltimore Classical Shock Research vs. Resuscitation Needs |
|
|
Uwe Kreimeier, M.D. Department of Anesthesiology, University of Munich Resuscitation Research in Europe |
|
10:00 |
BREAK |
|
10:20 |
PANEL 2: TREATMENT OF BATTLEFIELD TRAUMA (15-minute presentations, each followed by 5 minutes of discussion) |
|
|
Issues |
|
|
Steven P. Bruttig, Ph.D. Novel Technologies, Inc. Issues in Trauma Treatment on the Battlefield |
|
|
Frank Butler, Jr., M.D., Captain, USN Naval Special Warfare Command Detachment Pensacola Issues of Trauma Treatment for Special Forces |
|
|
Geoffrey S. F. Ling, M.D., Ph.D. Uniformed Services University of the Health Sciences Neurological Aspects of Battlefield Trauma |
|
|
Strategies |
|
|
Michael M. Krausz, M.D. RAMBAM Medical Center, Haifa, Israel Resuscitation Strategies in the Israeli Army |
|
|
George C. Kramer, Ph.D. University of Texas, Galveston Hypertonic Saline/Dextran Resuscitation: Novel Methods of Delivering Fluids on the Battlefield |
|
|
Monitoring |
|
|
Frederick J. Pearce, Ph.D. Walter Reed Army Institute of Research Casualty Resuscitation and Monitoring Devices Under Development by the U.S. Army |
|
12:20 p.m. |
LUNCH |
|
1:20 |
AGENDA ACCOMODATION I (15-minute presentations, each followed by 5 minutes of discussion) |
|
|
Jane Shelby, Ph.D. University of Utah Melatonin Therapy in Acute Trauma (from Panel 7) |
|
|
Richard McCarron, M.D. Naval Medical Research Institute Hibernation as a Model for Tolerance to Ischemia (from Panel 8) |
|
2:00 |
PANEL 3: ANIMAL MODELS OF HEMORHAGIC SHOCK (15-minute presentations, each followed by 5 minutes of discussion) |
|
|
Frederick J. Pearce, Ph.D. Walter Reed Army Institute of Research Animal Models of Hemorrhagic Shock and Physiological Responses to Hemorrhage |
|
|
Kenneth G. Proctor, Ph.D. University of Tennessee Models of Combined Hemorrhage and Injury |
|
|
Alfred Ayala, Ph.D. Rhode Island Hospital Effects of the Extent of Hypotension and Rates of Hemorrhage and Outcome in Animal Models |
|
3:00 |
BREAK |
|
3:20 |
PANEL 4: PATHOPHYSIOLOGY AND METABOLIC SEQUELAE (15-minute presentations, each followed by 5 minutes of discussion) |
|
|
Richard Veech, M.D., D.Phil. National Institute on Alcohol Abuse and Alcoholism National Institutes of Health Cellular Energetics and Fluid Design Issues |
|
|
Ajay Verma, M.D., Ph.D., Major, USA Uniformed Services University of the Health Sciences Strategies for Supporting Energy Demand During Resuscitation |
|
|
Edwin A. Deitch, M.D. New Jersey Medical School Sequelae of Hemorrhagic Shock (Intestinal Ischemia, Bacterial Translocation, ARDS) |
|
|
Irshad H. Chaudry, Ph.D. Rhode Island Hospital Immune and Endocrine Aspects of Hemorrhage |
|
|
Patricia E. Molina, M.D., Ph.D. North Shore University Hospital Cytokines in Hemorrhagic Shock |
|
|
Timothy R. Billiar, M.D. University of Pittsburgh Role of Induced Nitric Oxide Synthase in Hemorrhagic Shock |
|
5:20 |
CLOSING REMARKS |
|
|
David E. Longnecker, M.D. Committee Chair |
|
5:45 |
ADJOURN |
National Academy of Sciences Auditorium
2101 Constitution Avenue, N.W.
Washington, D.C.
|
Friday, September 18, 1998 |
|
|
8:15 a.m. |
OPENING REMARKS |
|
|
David E. Longnecker, M.D. Committee Chair |
|
8:25 |
PANEL 5: COMPLICATIONS OF RESUSCITATION (15-minute presentations, each followed by 5 minutes of discussion) |
|
|
Richard Veech, M.D., D.Phil. National Institutes of Health (for Kieran Clarke, Ph.D., Oxford University) Acute Toxicity of Lactate |
|
|
C. Robert Valeri, M.D. Boston University Red Blood Cells and Platelets in Hemostasis |
|
|
Peter Rhee, M.D. Uniformed Services University of the Health Sciences Stimulation of Inflammation by Standard Resuscitation Fluids |
|
|
Y. John Wang, Ph.D. Synzyme Tech., Inc., Irvine, Calif. Polynitroxyl-Albumin for Treatment of Reperfusion Injury |
|
|
Kenneth Mattox, M.D. Baylor University Complications of Fluid Resuscitation |
|
10:05 |
BREAK |
|
10:20 |
PANEL 6: NOVEL THERAPIES FOR HEMORRHAGE (15-minute presentations, each followed by 5 minutes of discussion) |
|
|
Alan S. Rudolph, Ph.D. Naval Research Laboratory Oxygen-Carrying Resuscitation Fluids |
|
|
Carleton J. C. Hsia, Ph.D. Synzyme Tech., Inc., Irvine, Calif. Reperfusion Injury in Hemorrhage as a Therapeutic Target |
|
|
Paul Segall, Ph.D. BioTime, Inc., Berkeley, Calif. Using Hextend to Treat Hemorrhagic Shock |
|
|
Bo E. Hedlund, Ph.D. Biomedical Frontiers, Inc. Beyond Volume Expansion: Treatment of Reperfusion Injury by Iron Chelation |
|
|
John L. Gainer, Ph.D. University of Virginia Fluid Additive for Promoting Oxygen Consumption |
|
|
T.M.S. Chang, M.D., Ph.D., M.R.C.P. McGill University, Montreal, Canada Polyhemoglobin-Superoxide Dismutase-Catalase: A New Blood Substitute |
|
12:20 p.m. |
LUNCH |
|
1:20 |
AGENDA ACCOMODATION II (15-minute presentations, each followed by 5 minutes of discussion) |
|
|
William P. Wiesmann, M.D., Colonel, USA, Retired Biostar Occult Hemorrhage Detection on the Battlefield by Means of Novel Microwave Sensors/Detectors (from Panel 2) |
|
|
John J. Lemasters, M.D., Ph.D. University of North Carolina Cellular Responses to Hypoxia (from Panel 4) |
|
2:00 |
PANEL 7: NOVEL THERAPIES FOR HEMORRHAGE (15-minute presentations, each followed by 5 minutes of discussion) |
|
|
Andrew Salzman, M.D. Cincinnati Children's Hospital Treatment of Hemorrhage with MEG |
|
|
Alan Kim Johnson, Ph.D. University of Iowa Treatment of Hemorrhage with Melanocyte-Stimulating Hormones |
|
|
William R. Millington, Ph.D. University of Missouri, Kansas City Neurobiology of Hemorrhagic Shock |
|
|
Florence M. Rollwagen, Ph.D. Uniformed Services University of the Health Sciences Oral Cytokines for Treatment of Hemorrhagic Shock |
|
|
Radha K. Maheshwari, Ph.D. Uniformed Services University of the Health Sciences Picroliv: Beneficial Effects in Hypoxia/Ischemia |
|
|
Barbara A. Araneo, Ph.D. Pharmadigm Biosciences Inc., Salt Lake City, Utah Intravenous DHEA in the Treatment of Burn Syndrome |
|
4:20 |
PANEL 8: HYPOTHERMIA IN TREATMENT OF HEMORRHAGE (15-minute presentations, each followed by 5 minutes of discussion) |
|
|
Samuel Tisherman, M.D. University of Pittsburgh Hypotensive Hypothermic Fluid Resuscitation During Uncontrolled Hemorrhagic Shock in Rats and Hypothermic Strategies for Suspended Animation with Delayed Resuscitation in Dogs |
|
|
Peter Safar, M.D. University of Pittsburgh Pharmacologic-Hypothermic Suspended Animation |
|
5:00 |
GENERAL DISCUSSION AND CLOSING REMARKS |
|
|
David E. Longnecker, M.D. Committee Chair |
|
5:30 |
ADJOURN |
